W. Riddle

Learn More
Current Positron Emission Tomography (PET) biomarkers for Alzheimer's disease (AD) assess either neuronal function, or associated pathological features of this common neurodegenerative disease. The most widely accepted clinical PET tool for AD is 18-fluorodeoxyglucose PET (FDG-PET), which measures cerebral metabolic glucose utilization rate (CMRglc).(More)
Automatic volumetric measurements of brain structures and substructures is a prerequisite for longitudinal studies as well as studies aimed at measuring and quantifying differences between populations. This study tests the hypothesis that a fully automatic, atlas–based method can be used for the computation of the volume encompassed by the dura, the volume(More)
  • 1